| dc.contributor | Echeverri Arcila, Darío | |
| dc.creator | Medina Lòpez, Libardo Augusto | |
| dc.creator | Gil Aldana, Victor José | |
| dc.date.accessioned | 2012-07-19T12:31:02Z | |
| dc.date.available | 2012-07-19T12:31:02Z | |
| dc.date.created | 2012-07-19T12:31:02Z | |
| dc.date.issued | 2012 | |
| dc.identifier | http://repository.urosario.edu.co/handle/10336/3617 | |
| dc.identifier | https://doi.org/10.48713/10336_3617 | |
| dc.description.abstract | Coronary artery disease (CAD) is still the first cause of morbidity and mortality in the general population. CAD has genetic, social, cultural, environmental and race backgroundsbesides the traditional major risks factors. It is unknown the impact of race in CAD´s severity within patients from Netherland Antilles, frequently referred to our service.
Purpose:To compare the severity and extension of multivessel coronary artery disease by SYNTAX score between patients from Netherland Antilles vs Colombian patients after matching by Framingham Score
Materials and Methods: We carried out a transversal cross sectional study by comparing patients from the Netherland Antilles vs Colombian patients after matching by Framingham Score in four categories (low risk, intermediate risk, high risk and very high risk). The patients correspond to those having multivessel coronary artery disease diagnosed by coronary angiography between January 2009 to June 2011.
Results: 115 Colombian patients and 115 patients coming from the Netherland Antilles were included in this study, in a 3:1 ratio between females and males.. The proportion of patients belonging to several groups of risk where as follows: 2.5% low risk, 15% intermediate risk, 19.3% high risk, and 63.4% very high risk. The Syntax score for coronary artery disease was significantly higher among Caribbean from the Netherland Antilles (22.2+/-10.5) than among Colombians (14.3+/-7.4) p: 0.002.
Conclusions: Patients coming from the Netherland Antilles had a higher severity index for coronary disease measured by angiography, after controlling for recognized risk factors. These findings support the notion that coronary disease is influenced by race, and genetic backgrounds. This finding is important for policies making in our service, a referral place for international patients. | |
| dc.language | spa | |
| dc.publisher | Universidad del Rosario | |
| dc.publisher | Especialización en Cardiología Intervencionista y Hemodinámia | |
| dc.publisher | Facultad de Medicina | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights | Abierto (Texto completo) | |
| dc.rights | Atribución-NoComercial-SinDerivadas 2.5 Colombia | |
| dc.rights | EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma.
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción
por parte de un tercero en cuanto a los derechos de autor sobre
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. | |
| dc.source | 1. Lloyd Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999; (353):89-92. | |
| dc.source | 2. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003; (290):891-7. | |
| dc.source | 3. Kate Jolly y Paramjit Gill. Ethnicity and cardiovascular disease prevention: practical clinical considerations. Curr Opin Cardiol. 200; (23):465-70. | |
| dc.source | 4. Meadows TA, Bhatt DL, Cannon CP, et al. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Mayo Clin Proc. 201; (86):960-7. | |
| dc.source | 5. Cooper RS, Kaufman JS, Ward R. Race and genomics (Sounding Board). N Engl J Med. 2003; (348):1166-70. | |
| dc.source | 6. Haga SB, Venter JC. FDA races in wrong direction. Science. 2003;(301):466. | |
| dc.source | 7. Shaw LJ, Liu ST, et al: Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardio. 2007; (50):953-60 | |
| dc.source | 8. Zaman MJ, Crook AM, Junghans C, et al. Ethnic differences in long-term improvement of angina following revascularization or medical management: a comparison between south Asians and white Europeans. J Public Health. 2009; (31):168-74. | |
| dc.source | 9. Jacobi JA, Parikh SV, McGuire DK, et al: Racial disparity in clinical outcomes following primary percutaneous coronary intervention for ST elevation myocardial infarction: influence of process of care. J Interv Cardiol. 2007; (20):182-7. | |
| dc.source | 10. Writing Group M, Lloyd-Jones D, Adams RJ, et al. Heart disease and stroke statistics 2010 update: A report from American Heart Association. Circulation. 2010; (121):e46-e215. | |
| dc.source | 11. Yancy C. Heart disease in varied populations, Vol 2, ed 7, Philadelphia, 2005, Saunders. | |
| dc.source | 12. Centers for Disease Control and Prevention (CDC): Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002; (51):300-3. | |
| dc.source | 13. Barua RS, Ambrose JA, Srivastava S, et al: Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: An in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003; (107):2342-7. | |
| dc.source | 14. Kurth T, Kase CS, Berger K, et al. Smoking and the risk of hemorrhagic stroke in men. Stroke. 2003; (34):1151-5. | |
| dc.source | 15. EzzatiM, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005; (112):489-97. | |
| dc.source | 16. He J, Vupputuri S, Allen K, et al. Passive smoking and the risk of coronary heart disease a meta-analysis of epidemiologic studies. N Engl J Med. 1999; (340):920-6. | |
| dc.source | 17. Otsuka R, Watanabe H, Hirata K, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA 2001, (286):436-41. | |
| dc.source | 18. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003; (290):86-97. | |
| dc.source | 19. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; (290):199-206. | |
| dc.source | 20. Glynn RJ, L'Italien GJ, Sesso HD, et al. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 2002; (39):105-10. | |
| dc.source | 21. Chaudhry SI, Krumholz HM, Foody JM. Systolic hypertension in older persons. JAMA. 2004; (292):1074-80. | |
| dc.source | 22. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001; (345):1291-7. | |
| dc.source | 23. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; (289):2560-72. | |
| dc.source | 24. Mehler PS, Coll JR, Estacio R, et al. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 2003; (107):753-6. | |
| dc.source | 25. Collins R, Armitage J, Parish S, et al: Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004 ;(363):757-67. | |
| dc.source | 26. de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA 2004; (292):1307-16. | |
| dc.source | 27. LaRosaJC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; (352):1425-35. | |
| dc.source | 28. Brewer Jr HB. Increasing HDL cholesterol levels. N Engl J Med 2004;(350):1491-4. | |
| dc.source | 29. Forrester JS, Makkar R, Shah PK: Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: An update for clinicians. Circulation 2005; (111):1847-54. | |
| dc.source | 30. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: A population-based retrospective cohort study. Lancet 2006; (368):29-36. | |
| dc.source | 31. Howard BV, Rodriguez BL, Bennett PH, et al: Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology. Circulation. 2002; (105):e132-7. | |
| dc.source | 32. Gillum RF, Mussolino ME, Madans JH. Diabetes mellitus, coronary heart disease incidence, and death from all causes in African American and European American women: The NHANES I epidemiologic follow-up study. J ClinEpidemiol. 2000; (53):511-8. | |
| dc.source | 33. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;(287):2570-81. | |
| dc.source | 34. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; (106):3143-421. | |
| dc.source | 35. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group.Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; (286):180-7. | |
| dc.source | 36. Liu J, Hong Y, D'Agostino RB Sr, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004; (291):2591-9. | |
| dc.source | 37. Jones DW, Chambless LE, Folsom AR, et al. Risk factors for coronary heart disease in African Americans. The Atherosclerosis Risk in Communities Study, 1987–1997. Arch Intern Med. 2002; (162):2565–2571. | |
| dc.source | 38. Chambless LE, Folsom AR, Sharrett AR, et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J ClinEpidemiol. 2003; (56):880–90. | |
| dc.source | 39. Swenson CJ, Trepka MJ, Rewers MJ, et al. Cardiovascular disease mortality in Hispanics and non-Hispanic Whites. Am J Epidemiol. 2002; (156):919–928 | |
| dc.source | 40. Festa A, D’Agostino R, Rich SS, et al. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites. The Insulin Resistance AtherosclerosisStudy. Circulation. 2003; (107):2422–27. | |
| dc.source | 41. Lu W, Resnick HE, Jablonski KA, et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes. The Strong Heart Study. DiabetesCare. 2003; (26):16–23 | |
| dc.source | 42. Hatwalkar A, Agrawal N, Reiss DS, Budoff MJ. Comparison of prevalence and severity of coronary calcium determined by electron beam tomography among various ethnic groups. Am J Cardiol. 2003; (91):1225–27 | |
| dc.source | 43. Swenson CJ, Trepka MJ, Rewers MJ, et al. Cardiovascular disease mortality in Hispanics and non-Hispanic Whites. Am J Epidemiol. 2002; (156):919–28. | |
| dc.source | 44. Bild DE, Detrano R, Liu K, et al. Ethnic differences in coronary calcification:the multi-ethnic study of atherosclerosis. Circulation. 2003; (107):e7001. | |
| dc.source | Lee TC, O’Malley PG, Feuerstein I, et al. The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects. J Am CollCardiol. 2003; (41):39–44. | |
| dc.source | 46. Meadows TA, Bhatt DL, Cannon CP, et al. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Mayo Clin Proc. 2011; (10):960-7. | |
| dc.source | 47. M. Justin Zaman, Angela M. Crook, Cornelia Junghans, et al. Ethnic differences in long-term improvement of angina following revascularization or medical management: a comparison between south Asians and white Europeans. Journal of PublicHealth. ( 31): 168–74 | |
| dc.source | 48. Chen MS, Bhatt DL, Chew DP, et al: Outcomes in African American and whites after percutaneous coronary intervention. Am J Med. 2005; (9):1019-25. | |
| dc.source | 49. Iqbal U, Pinnow EE, Lindsay J, Jr: Comparison of six-month outcomes after percutaneous coronary interventions for whites vsAfican-Americans. Am J Cardiol. (3):304-5 | |
| dc.source | 50. Leborgne L, Cheneau E, Wolfram R, et al: Comaparison of baseline characteristics and one-year outcomes between African Americans and Caucasians undergoing percutaneous coronary intervention. Am J Cardiol. 2004; (4):389-93. | |
| dc.source | 51. Slater J, Selzer F, Dorbala S. et al: Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, anda Blood Institute Dynamic Registry). Am J Cardiol. 2003; (7):773-8. | |
| dc.source | 52. Sianos G, Morel MA, Kappetein AP, Morice MC, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219. | |
| dc.source | 53. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360(10):961 | |
| dc.source | 54. Summer AE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr. 2009; 155(3):S7.e7-11. | |
| dc.source | 55. Meadows TA, Bhatt DL, Cannon CP, et al. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Mayo Clin Proc. 2011; 86(10):960-7. | |
| dc.source | 56. Roberts R, Stewart AF. The genetics of coronary artery disease CurrOpinCardiol. 2012 Feb 29 | |
| dc.source | 57. Rosengren A, Subramanian SV, Islam S, et al. Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study. Heart. 2009; 95(24):2014-22. | |
| dc.source | 58. Hu FB. Diet and lifestyle influences on risk of coronary heart disease. CurrAtheroscler Rep. 2009 Jul; 11(4):257-63. | |
| dc.source | instname:Universidad del Rosario | |
| dc.source | reponame:Repositorio Institucional EdocUR | |
| dc.subject | Enfermedad coronaria | |
| dc.subject | Syntax Score | |
| dc.title | Comparación de la severidad y extensión de la enfermedad coronaria multivaso por Syntax Score en una poblaciòn de las Antillas Holandesas vs controles nacionales | |
| dc.type | masterThesis | |
